Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS – Get Free Report) Director Jeffrey L. Ives sold 41,949 shares of the stock in a transaction on Thursday, August 17th. The stock was sold at an average price of $6.49, for a total value of $272,249.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, […]